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Arteriosclerotic vascular disease is the most common cause of death and a major cause of
disability in the developed world. Adverse outcomes of arteriosclerotic vascular disease are
related to consequences of tissue ischemia and necrosis affecting the heart, brain, limbs,
and other organs. Collateral artery growth or arteriogenesis occurs naturally and can help
restore perfusion to ischemic tissues. Understanding the mechanisms of collateral artery
growth may provide therapeutic options for patients with ischemic vascular disease. In this
review, we examine the evidence for a role of monocytes and macrophages in collateral
arteriogenesis.
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INTRODUCTION
Arteriosclerotic disease is the major cause of death, and a major
cause of morbidity and healthcare expenditure in the devel-
oped world. The clinical consequences of arteriosclerotic dis-
eases are primarily related to the acute and chronic effects of
tissue ischemia and necrosis affecting particularly the heart,
brain, and limbs. Revascularization strategies have been employed
with the goal of restoring blood flow to the ischemic tissue.
Approaches to restoring blood flow through occluded or highly
narrowed vessels include thrombolytic therapy, percutaneous
interventional procedures (e.g., balloon angioplasty, stenting),
and surgery (e.g., carotid endarterectomy, coronary artery bypass
grafting).
In situations of acute ischemia presenting as acute myocardial
infarction, stroke or acute limb ischemia, emergent restoration of
blood flow by pharmacological therapy (thrombolytic therapy) or
percutaneous interventional procedures is essential for limiting
tissue necrosis. However, the risk/benefit ratio of revasculariza-
tion procedures often becomes less clear in situations of chronic
ischemia. Furthermore, the above approaches may not always be
feasible for patients with severe diffuse occlusive arterial disease
and poor target vessels for grafting. The costs and potential short-
and long-term complications of surgical and percutaneous inter-
ventional procedures are not always offset by the variable extent
of the benefits. The risks associated with current revasculariza-
tion approaches include acute thrombotic occlusion or gradual
restenosis of stents, and occlusion of bypass grafts. While coronary
artery bypass grafting using certain arterial conduits (e.g., internal
mammary artery) have relatively high patency rates of 85–90%
after 10 years, venous conduits (e.g., saphenous vein grafts) are
patent only 55–70% of the time after 10 years and 50–60% after
15 or more years (Fitzgibbon et al., 1996; Goldman et al., 2004;
Tatoulis et al., 2004; Sabik et al., 2005).
Humans, like other organisms with vascular systems, have
the capacity to grow vessels during early development as well
as in adulthood. Functional studies on vascular growth began
in 1785 with the Scottish anatomist, physiologist, and surgeon,
Sir John Hunter (1728–1793), who documented his findings on
the occlusion of the external carotid artery of a buck, and its
physiologic consequences. He observed that the animal’s ipsilat-
eral antler became cool to touch and its arterial pulse became
impalpable, as its blood supply was dependent on the ligated
artery. However, when the animal was reexamined a week later,
the temperature and arterial pulsations of the antler had normal-
ized. On further examination, Hunter found that small branches
of the artery above and below the ligature had enlarged, and
through their anastomoses the blood supply was restored (Murley,
1984). Well over two centuries later, this compensatory physi-
ologic process, particularly at the cellular and molecular level,
remains largely unclear. In this article, we review the different
major mechanisms of natural vascularization and focus on the
evidence for monocytes and macrophages in collateral artery
growth.
VASCULAR GROWTH PROCESSES IN DEVELOPING AND ADULT
ORGANISMS
The vascular system is the first functional organ system in ver-
tebrates. Vasculogenesis is the de novo formation of a primary
capillary plexus from mesenchymal-derived progenitor or stem
cells (Risau et al., 1988; Jin and Patterson, 2009). This is followed
by sprouting and non-sprouting angiogenesis, arterial and venous
specification, recruitment of smooth muscle cells with further
arterial growth, differentiation, outward remodeling and inward
remodeling/pruning (Risau, 1997; Carmeliet, 2005).
Vascular growth processes continue after birth and are nec-
essary for maintaining physiologic homeostasis including organ
growth, wound healing, and the menstrual changes of the uterine
mucosa. Angiogenesis plays a role in many pathological con-
ditions, ranging from inflammatory diseases to tumorigenesis
(Carmeliet, 2005; Cao et al., 2011).
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VASCULAR GROWTH PROCESSES IN PATIENTS WITH
ATHEROSCLEROTIC VASCULAR DISEASES AND IN ANIMAL MODELS OF
ARTERIAL OCCLUSIONS
Vascular growth occurs in situations of arterial occlusive dis-
ease. In regions of tissue ischemia and tissue necrosis, capillary
angiogenesis and arteriolar growth have been observed (Helisch
and Schaper, 2003; Nickerson et al., 2009a; Mac Gabhann and
Peirce, 2010). Since the initial report by Asahara, Isner and col-
leagues, the possibility of postnatal vasculogenesis in regions of
tissue ischemia and tissue necrosis generated much interest (Asa-
hara et al., 1997; Kalka et al., 2000; Moldovan et al., 2000; Urbich
et al., 2003; Tepper et al., 2005). However, the contribution of post-
natal vasculogenesis to compensatory blood vessel growth in adult
organisms has been refuted by a number of studies failing to find
evidence for any significant degree of bone marrow-derived cells
transdifferentiating into vascular wall cells in arterial occlusion,
tissue ischemia, hypoxia, or growth factor stimulation (Beck et al.,
2003; Ziegelhoeffer et al., 2004; O’Neill et al., 2005; Capoccia et al.,
2006; Grunewald et al., 2006; You et al., 2006; Nickerson et al.,
2009a,b).
The size, location, and connectedness of growing vessels are
major determinants of their contribution to improving blood flow
to ischemic tissue. For example, in a patient with proximal occlu-
sion of a leg artery, severity of ischemia is worst in the distal
portion of the limb, where capillary angiogenesis and arteriolar
growth may occur. However, as the arterial occlusion is proximal,
blood flow to the limb is primarily limited by the increased prox-
imal arterial resistance and only arteries that functionally bridge
or bypass the occlusion have the potential to completely com-
pensate for the occluded artery (Unthank et al., 1995; Helisch
and Schaper, 2003; Simons, 2005; Ziegler et al., 2010). Figure 1
and Movie 1 (Supplementary Material) are examples of a patient
with complete arteriosclerotic occlusion of the mid left anterior
descending artery that has been functionally bypassed by collater-
als from branches of the right coronary artery (Figure 1). Figure 2
shows a complete arteriosclerotic occlusion of the right internal
iliac artery in another patient in whom well-developed collateral
arteries have formed. This process is distinct from other processes
of vascular growth, and has been termed “collateral (artery)
growth/remodeling,”“arteriogenesis,” or “collaterogenesis.”
HOW DO COLLATERAL ARTERIES DEVELOP? DE NOVO DEVELOPMENT
OR OUTWARD REMODELING OF PREEXISTING VESSELS?
Direct vascular connections between arteries or arterioles have
been demonstrated in many species and organs (Helisch and
Schaper, 2003). These interarterial connections may be at the level
of arteries, arterioles, and even capillaries (Helisch and Schaper,
2003; Mac Gabhann and Peirce, 2010). The circle of Willis at the
base of the human brain and the arterial supply of the hands and
feet of humans are examples of arterial networks where occlusion
of one vessel may not result in any tissue ischemia, as blood flow
through a parallel vessel may be adequate. Smaller, mostly arterio-
lar, preexisting interarterial connections are present in canine and
human hearts and in the hind limbs of rodents (Herzog et al., 2002;
Scholz et al., 2002; Helisch and Schaper, 2003; Wustmann et al.,
2003; Helisch et al., 2006). After femoral artery ligation in different
mouse strains, we observed the impact of differences in the innate
FIGURE 1 | Coronary angiography of a 69-year-old male with chest
pain (Canadian Cardiovascular Society Class IV) revealed occlusive
coronary artery disease in the mid segment of the left anterior
descending artery (∗) bypassed naturally with collateral arterioles (↓)
from the right coronary artery.The figure is taken from the cineangiogram
in Supplementary Material during contrast injection into the right coronary
artery. C, angiographic catheter; RCA, right coronary artery. Supplementary
Material (Movie 1.MPG).
collateral vasculature between BALB/c and C57BL/6 mice, and
demonstrated, at least in the less ischemia-prone C57BL/6 strain,
that collateral artery growth can be entirely based on the outward
remodeling of innate collateral arterioles without any evidence for
capillary angiogenesis in the region of collateral growth (Helisch
et al., 2006). A recent elegant confocal microscopy study in spin-
otrapezius muscles revealed mouse strain-dependent differences
in the skeletal muscle microvasculature, and demonstrated the
ability of inter-arterially connecting capillaries to arterialize (Mac
Gabhann and Peirce, 2010). Those findings lend further support
to genetic (animal strain) differences being a source of inconsis-
tency in the literature on experimentation on the innate collateral
vasculature using different femoral artery ligations models.
While hypoxia is a potential stimulus for collateral arterial
growth (Chilian et al., 2012), local tissue hypoxia is not essen-
tial for collateral arteriogenesis in the hind limb (Ito et al., 1997a;
Deindl et al., 2001; Helisch et al., 2006) or the mesenteric circula-
tion (Unthank et al., 1996). Increasing blood flow through innate
collaterals by surgical manipulation (by creation of an arterio-
venous shunt distal to the arterial ligation) appears to be one of
the most powerful ways to increase their growth (Eitenmuller et al.,
2006). This suggests that the mechanical forces of increased unidi-
rectional blood flow in preexisting collateral arterioles after arterial
occlusion are of major importance for their growth and matura-
tion into collateral arteries, analogous to flow-induced remodeling
known from other experimental models and clinical observations
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FIGURE 2 | Digital subtraction angiography performed during
abdominal aortography and peripheral arteriography on a 68-year-old
female with lifestyle-limiting intermittent claudication showing an
occluded right common iliac artery (∗), and development of collateral
vessels (↓) involving the middle sacral artery, right lumbar arteries, and
other branches, to supply the right lower extremity. Compared with
arteries on the left side, note the extensive outward remodeling on the
right characterized by increased vessel diameter, tortuosity, and density as
a consequence of the right-sided occlusion. Ao, abdominal aorta; LCIA, left
common iliac artery; LLA, left lumbar artery; MSA, middle sacral artery;
RLA, right lumbar artery.
(Unthank et al., 1996; Helisch and Schaper, 2003; Schaper, 2009).
The clinical example of peripheral vascular disease in Figure 2
illustrates how even large arteries enlarge as a consequence of the
increased collateral blood flow.
Histologically, collateral artery remodeling is characterized by
breakdown of the basement membrane, phenotypic modulation
of vascular smooth muscle cells of the tunica media (from a con-
tractile to a proliferative phenotype), cellular proliferation and
apoptosis in all layers of the developing vessel, alteration in phys-
ical dimensions (the diameter and later the wall thickness of the
vessel), and finally, reversion of the vascular smooth muscle cells
to a contractile phenotype. The extent of growth in diameter and
wall thickness tends to be much greater in dogs and rabbits than
in rodents (Scholz et al., 2000, 2002; Cai et al., 2003; Helisch
and Schaper, 2003; Schaper, 2009). Mice differ from non-rodent
species in that a neointima is not observed during collateral arterial
growth (Scholz et al., 2002).
While the remodeling of preexisting collateral vessels to col-
lateral arteries has become an accepted mechanism for collateral
artery growth, it remains unclear to what extent and under what
conditions true de novo growth of collateral arterial vessels occurs,
especially when the density of innate collaterals at the arteriolar or
capillary level is low.
A B
FIGURE 3 | (A) Donor-derived cells (labeled with anti-GFP antibody, green)
accumulating around collateral artery, after bone marrow transplantation
from GFP expressing donor mice and femoral artery ligation. (B) Several of
the bone marrow-derived cells express F4/80 (red), a marker for
macrophages. With permission from (Ziegelhoeffer et al., 2004).
MONOCYTES AND MACROPHAGES IN COLLATERAL
ARTERIOGENESIS
MONOCYTES/MACROPHAGES ACCUMULATE IN REGIONS OF GROWING
COLLATERAL ARTERIES
The concept that monocytes or macrophages play a role in col-
lateral artery growth can be traced back to the pioneering histo-
logical studies of growing collateral vessels by Wolfgang and Jutta
Schaper and their associates in the 1960s–1970s. After gradual
coronary artery occlusion by ameroid constrictors in dogs, adher-
ent monocytes were observed on the luminal side of the endothe-
lium of growing collateral arteries, with evidence of diapedesis
of these cells through the endothelium into the subintimal space
(Schaper et al., 1976). Accumulation of monocytes/macrophages
was observed around growing collateral arteries after femoral
artery ligation in the hind limb of rabbits (Arras et al., 1998;
Scholz et al., 2000), and mice (Scholz et al., 2002; Ziegelhoeffer
et al., 2004). In these femoral artery ligation models, perivascu-
lar monocyte/macrophage accumulation peaked within the first
3 days, followed by a gradual decline at various times (Arras et al.,
1998; Scholz et al., 2000; Khmelewski et al., 2004). Of note, other
leukocyte subpopulations were also present around growing col-
lateral vessels (Stabile et al., 2003, 2006; Ziegelhoeffer et al., 2004;
Figure 3).
MECHANISMS OF MONOCYTE/MACROPHAGE RECRUITMENT AND
EVIDENCE FOR FUNCTIONAL RELEVANCE IN ARTERIOGENESIS
Recruitment of mononuclear phagocytes to tissues is a local and
systemic process requiring chemotactic cytokines (chemokines)
and adhesion molecules. The process is a continuum invoking
bone marrow cell mobilization, monocyte emigration from bone
marrow, chemotaxis, cell rolling along the endothelium, retention
by adhesion, and transmigration through diapedesis (Luster et al.,
2005; Serbina and Pamer, 2006; Rao et al., 2007).
Several studies have suggested that the number of circulating
monocytes at or shortly after the time of arterial ligation corre-
lated with collateral artery growth. These experiments involved
the performance of arterial ligations in mice after depletion, or
during the rebound phase, of circulating cells following admin-
istration of 5-fluorouracil (5-FU; Heil et al., 2002; Pipp et al.,
2003), bisphosphonate-containing liposomes (Pipp et al., 2003),
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or reconstitution of monocytes around the time of surgery (Heil
et al., 2002; Pipp et al., 2003; Cochain et al., 2010). These experi-
mental approaches have broad physiologic effects, and thus, leave
much room for data interpretation. For instance, cytostatic agents
such as 5-fluorouracil do not selectively affect monocytes, and
thus, the collateral growth promoting effects of the infused,crudely
separated mononuclear cells would not be restricted to one spe-
cific cell subset, as claimed by a number of studies. Various types
of mononuclear cells, have been referred to as “endothelial prog-
enitor cells” or “circulating angiogenic cells” (Kalka et al., 2000;
Rehman et al., 2003; Urbich et al., 2003), as well as adipose stro-
mal cells (Rehman et al., 2004). The intramuscular administration
of even platelets in a hind limb ischemia model of athymic nude
rats reportedly augmented collateral arterial growth and associ-
ated with an accumulation of the injected cells around arterioles
in the regions of arteriogenesis (Iba et al., 2002). Interestingly,
a rat femoral artery ligation study using cyclophosphamide to
deplete circulating cells did not find an effect on the number of
accumulating macrophages around collateral arteries, or on arte-
riogenesis as assessed by bromodeoxyuridine (BrdUrd) uptake.
Furthermore, the authors did not find any accumulation of flu-
orescently labeled blood cells around growing collateral vessels
that had been injected intraarterially immediately after arterial
ligation. The authors concluded that circulating monocytes did
not accumulate around growing collateral arteries, and that the
local proliferation of tissue-resident macrophages was of primary
importance for collateral artery growth (Khmelewski et al., 2004).
Concerns about that interpretation relate to the assessment of
arteriogenesis using only BrdUrd uptake which may have lacked
sensitivity for the detection of differences in collateral growth
compared to methods of flow measurement. Furthermore, the
continuous administration of intraarterial BrdUrd after arterial
ligation could have labeled macrophage precursors before their
emigration from the bone marrow. However, the possibility of
in situ proliferation of the “M2” subpopulation of macrophages
has recently been suggested by a study employing mouse models
of pleural and peritoneal inflammation (Jenkins et al., 2011).
At least in cell culture, laminar flow can increase the expression
of granulocyte-macrophage colony-stimulating factor (GM-CSF)
in human umbilical vein endothelial and bovine aortic endothe-
lial cells (Kosaki et al., 1998). This may be relevant for collateral
arteriogenesis, as the mechanical forces of increased blood flow
through preexisting collaterals after occlusion of a large artery
may be the first alteration of the environment affecting endothe-
lial cells of preexisting collateral vessels. Also, even transient shear
stress-induced upregulation of monocyte chemoattractant pro-
tein (MCP-1; Shyy et al., 1994), intercellular adhesion molecule-1
(ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) have
been reported; these factors are well-recognized in promoting
monocyte recruitment and adhesion to the endothelium (Scholz
et al., 2000; Rao et al., 2007). The observed expression of MCP-
1, VEGF, and ephrinB2 on the endothelium of growing collateral
vessels may be of importance for the recruitment of monocytes
and macrophages in vivo (Scholz et al., 2000; Ziegelhoeffer et al.,
2004; Korff et al., 2008).
Granulocyte-macrophage colony-stimulating factor promotes
recruitment of monocytes/macrophages and arteriogenesis in
animal models of hind limb (Buschmann et al., 2001) and cerebral
ischemia (Buschmann et al., 2003; Schneeloch et al., 2004; Todo
et al., 2008; Sugiyama et al., 2011). Subcutaneous GM-CSF was
demonstrated to promote coronary collateral growth in a study of
14 patients with chronic stable coronary artery disease (Zbinden
et al., 2005). Unfortunately, two of the seven patients in the GM-
CSF group experienced acute coronary events, which did not occur
in any of the seven control patients (Zbinden et al., 2005). In a
study of 40 patients with peripheral vascular disease and claudica-
tion, repeated subcutaneous GM-CSF administration over 14 days
did not influence the outcome as assessed by walking distance and
ankle-brachial indices (van Royen et al., 2005).
Osteopetrotic (Csf1op/Csf1op) mice are deficient in colony-
stimulating factor (CSF)-1, a growth factor that regulates the
survival, proliferation, and differentiation of mononuclear phago-
cytic cells (Marks and Lane, 1976; Dai et al., 2002); these animals
reportedly have impaired collateral artery growth, a reduction in
the number of circulating monocytes and lymphocytes, and an
increased number of circulating granulocytes (Bergmann et al.,
2006). Granulocyte colony-stimulating factor (G-CSF) promoted
macrophage (or leukocyte) accumulation and arteriogenesis in
animal models of arteriogenesis in the hind limb (Lee et al., 2005;
Capoccia et al., 2006) and brain (Sugiyama et al., 2011). Subcu-
taneous administration of G-CSF improved coronary collateral
growth in a trial of 54 patients with chronic stable coronary artery
disease (Meier et al., 2009).
MCP-1 is a ligand specific for C–C chemokine receptor (CCR2)
with demonstrated importance in monocyte/macrophage recruit-
ment. In studies using rabbit and porcine hind limb mod-
els of femoral artery ligation, Wolfgang Schaper and colleagues
demonstrated that direct intraarterial infusion of MCP-1 led
to an increase in collateral artery development in association
with increased monocyte/macrophage accumulation around the
growing collateral arteries (Ito et al., 1997b; Hoefer et al., 2001;
Heil et al., 2002; Voskuil et al., 2003). A study using a femoral
artery excision model reported that skeletal muscle tissue levels
of MCP-1 were highest on day 3, paralleling the regenerative
response in ischemic muscle (Shireman et al., 2006). MCP-1-
deficient (Ccl2–/–) mice exhibited delayed or reduced collateral
artery development or perfusion recovery in several independent
studies (Voskuil et al., 2004; Shireman et al., 2007; Cochain et al.,
2010) and consistently had abnormal monocyte recruitment (Lu
et al., 1998; Voskuil et al., 2004). The MCP-1-induced increase
of collateral growth can be abrogated by monoclonal antibody
targeting ICAM-1 (Hoefer et al., 2004), highlighting the integral
coupling of chemotaxis and leukocyte adhesion,and strengthening
the concept of monocyte/macrophage-mediated arteriogenesis.
Unfortunately, MCP-1 promotes not only arteriogenesis but also
atherosclerosis (van Royen et al., 2003).
Following initial studies on MCP-1, focus was later shifted
to its receptor, CCR2. CCR2 and CX3CR1 (fractalkine recep-
tor) are probably the most well-studied chemokine receptors in
monocytes/macrophages to date (Ancuta et al., 2003; Charo and
Peters, 2003; Geissmann et al., 2003; Serbina and Pamer, 2006;
Swirski et al., 2007; Tacke et al., 2007). Their differential sur-
face expression levels can aid in classifying at least two major
monocyte subsets defined by their physical properties (e.g., cell
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size, cytoplasmic granularity) and divergent physiologic functions
(Geissmann et al., 2003, 2010; Gordon and Taylor, 2005; Fung et al.,
2010; Butcher and Galkina, 2012). CCR2 and CX3CR1 play critical
roles during infection, in maladapted inflammatory disorders, and
in establishing homeostasis (Boring et al., 1998; Izikson et al., 2000;
Serbina and Pamer, 2006; Auffray et al., 2007; Swirski et al., 2007;
Tacke et al., 2007; Swirski, 2011). Promiscuity of CCR2 has raised
challenges in the interpretation of studies using CCR2-deficient
animals due to potential compensatory changes and overlapping
properties of chemokines and adhesion mechanisms (Olson and
Ley, 2002; Charo and Ransohoff, 2006; Shireman et al., 2007).
Studies using CCR2-deficient (Ccr2–/–) animals have reported
variable results in restoration of perfusion following hind limb
ischemia (Heil et al., 2004; Tang et al., 2004; Contreras-Shannon
et al., 2007; Nickerson et al., 2009b). In a femoral artery ligation
study a mildly decreased blood flow recovery with reduced perivas-
cular and adventitial accumulation of macrophages in Ccr2–/–
mice on C57BL/6 background was found; however a much more
pronounced deficit in perfusion recovery and in gracilis muscle
collateral arteriolar growth inCcr2–/– mice on BALB/c background
was observed (Heil et al., 2004). At least to some degree these
background strain related differences in the effects of Ccr2 dele-
tion are probably related to differences in the innate collateral
vasculature (Helisch et al., 2006). On the other hand, two other
groups using a more severe ischemia surgical model observed
unchanged perfusion recovery in Ccr2–/– compared to wild-type
animals (Tang et al., 2004; Contreras-Shannon et al., 2007). In one
study this was associated with decreased monocyte/macrophage
recruitment only in the more ischemic calf muscle of Ccr2–/–
mice, but not in the thigh, where collateral growth occurred (Tang
et al., 2004), while the other one only assessed macrophages in the
calf muscles; where decreased recruitment was observed. Interest-
ingly, a more recent intravital microscopy study using mouse bone
marrow chimeras and a dorsal skinfold window chamber model
of injury/inflammation induced arteriolar remodeling reported
significantly reduced accumulation of F4/80+ macrophages and
abolition of arteriolar remodeling with Ccr2 deficiency in bone
marrow-derived cells (Nickerson et al., 2009b).
Mice with either MCP-1 or CXCR3 deficiency had similar
decreases in their collateral arterial growth in the thighs, capillary
density in the distal hind limbs, and in recovery of perfusion after
femoral artery ligation, which was associated with a decrease in
recruitment of macrophages and CD3+ T lymphocytes (Waeckel
et al., 2005). In Cxcr3-deficient mice, vascular growth and perfu-
sion recovery could be normalized by a single intravenous infusion
of bone marrow-derived mononuclear cells from wild-type ani-
mals, but not from Cxcr3–/– mice 5 h after femoral artery ligation
(Waeckel et al., 2005), supporting the importance of CXCR3-
expressing mononuclear cells in the very early stages of arteriogen-
esis. CXCR3 expression was also found to be essential for inward
remodeling of the common carotid artery in response to decreased
blood flow which is accompanied by adventitial macrophage accu-
mulation (Zhou et al., 2010). CXCR3 deficiency reduced adven-
titial macrophage recruitment and abrogated inward remodeling
as assessed by arterial diameter measurements (Zhou et al., 2010).
Moreover, the authors found that impaired flow-mediated vascu-
lar remodeling in Cxcr3–/– animals could be restored by myeloid
cells transferred from the wild-type counterpart, and that accumu-
lation of perivascular macrophages was CXCR3-dependent. Extra-
cellular matrix turnover mediated by macrophages was reportedly
CXCR3-dependent (Zhou et al., 2010).
CX3CR1 and CX3CL1 (fractalkine) mediate the homeostatic
functions of monocyte subsets, ranging from tissue and blood
vessel patrolling (Auffray et al., 2007), monocyte recruitment in
the spleen (Auffray et al., 2009) to their maladapted use in mono-
cyte/macrophage accumulation in atherogenesis (Swirski et al.,
2007; Tacke et al., 2007). The endothelium is a rich source of
CX3CL1 that specifies migration and adhesion of monocytes and
T cells (Bazan et al., 1997; Imai et al., 1997), and is a crucial
gatekeeper in regulating leukocyte trafficking as well as a host of
vascular and immune functions.
Local intramuscular injection of rat-specific CX3CL1 into
the regions of collateral growth dose-dependently increased
limb perfusion recovery after common femoral artery occlusion
using an intraarterial coil approach, which avoids the prob-
lem of a local surgical wound (Ryu et al., 2008). While these
studies implicated monocytes/macrophages in the process of
neovascularization and arteriogenesis via the CX3CR1–CX3CL1
interaction, other circulating antigen-presenting cells including
myeloid dendritic cells also express CX3CR1 and CD80 (B7-
1), cell surface markers that have limited specificity in defining
monocytes/macrophages. Furthermore, another study suggested
that the CX3CR1–CX3CL1 interaction, which mediates recruit-
ment of the Ly6Clo7/4lo subset of monocytes, corresponding
to the human CD16+CD14lo “resident/patrolling” subset (Auf-
fray et al., 2007), was unimportant for arteriogenesis compared
to the CCL2/CCR2 pathway, which mediates recruitment of
the “inflammatory” Ly6Chi7/4hi subset-equivalent to the human
CD14hi CD16− subpopulation (Cochain et al., 2010). Hind limb
ischemia in this murine femoral artery ligation study was asso-
ciated with a transient decrease of Ly6Chi7/4hi cells in the bone
marrow, supporting the hypothesis that these early accumulat-
ing cells are mobilized from the bone marrow. Interestingly,
infusion of both monocyte subsets 6 h after femoral artery
ligation resulted in an increase of vascular growth by angio-
graphic score; however, only infusion of the Ly6Chi7/4hi subset
also resulted in an increased blood flow recovery (Cochain et al.,
2010).
Recently, it was shown that the reticulon family member 4B
(Nogo-B), which is known to be expressed by endothelial and vas-
cular smooth muscle cells (Acevedo et al., 2004), is also expressed
by macrophages and is important for some macrophage func-
tions, including migration, spreading, and chemotaxis to MCP-1
and CSF. In a hind limb ischemia model, mice lacking Nogo-B had
reduced collateral arteriogenesis and angiogenesis associated with
a decrease in macrophage recruitment. Bone marrow reconstitu-
tion experiments showed that Nogo in myeloid cells plays a role in
macrophage homing and blood flow recovery after limb ischemia
(Yu et al., 2009).
HOWMAY MONOCYTES/MACROPHAGES PROMOTE COLLATERAL
ARTERIOGENESIS?
Early studies on corticosteroids in modulating the develop-
ment of collaterals suggested a role for inflammatory events in
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arteriogenesis (Borgers et al., 1973; Schaper et al., 1973). The
first evidence for activated macrophages promoting angiogene-
sis was demonstrated by Polverini et al. (1977) in the avascular
guinea pig cornea. While the potentiating effects of macrophages
in neovascularization, especially tumor angiogenesis, are well-
recognized (Mantovani et al., 2002; Pollard, 2004; Condeelis and
Pollard, 2006), their potential effects in collateral artery growth
have become a focus of study only since the late 1990s (Ito et al.,
1997b; Arras et al., 1998).
While the ability of monocytes/macrophages to transdifferen-
tiate into endothelial cells has been suggested based on in vitro
studies (Fernandez Pujol et al., 2000; Schmeisser et al., 2001), evi-
dence does not support this mechanism as relevant for arteriogen-
esis and even angiogenesis in ischemic conditions (Ziegelhoeffer
et al., 2004; Capoccia et al., 2006; Nickerson et al., 2009a).
However, there is convincing evidence that monocytes and
macrophages promote vascular growth in general, and arterio-
genesis through paracrine effects. Monocytes and macrophages
are capable of producing a large variety of growth factors, met-
alloproteinases, chemokines, vasoactive substances such as nitric
oxide, all of which can facilitate arteriogenesis.
Growth factors
For a long time it has been known that activated macrophages
can secrete substances which stimulate microvascular growth,
as initially demonstrated in a guinea pig corneal angiogenesis
model (Polverini et al., 1977). Monocytes/macrophages accumu-
lating around collaterals express growth factors including VEGF-A
(Ziegelhoeffer et al., 2004) and fibroblast growth factor (FGF)-2
(Arras et al., 1998; Ziegelhoeffer et al., 2004) that promote pro-
liferation of endothelial and vascular smooth muscle cells (Sato
et al., 2000; Schaper, 2009; Poling et al., 2011) which are essential
processes for arteriogenesis. Growth factors also have chemotac-
tic effects, as shown by the effect of VEGF-A on macrophages
via VEGF receptor 1 (VEGF-R1). VEGF-A–VEGF-R1 signaling
may be the mechanism by which placental growth factor (PGF),
a selective VEGF-R1 agonist, augments macrophage recruitment
to regions of collateral artery growth (Luttun et al., 2002; Pipp
et al., 2003). Furthermore, there is compelling evidence that cer-
tain growth factors have direct tissue protective effects in situations
of ischemia unrelated to vascular growth per se (House et al., 2003;
Suzuki et al., 2005).
Metalloproteinases
MMPs are the primary proteolytic enzymes responsible for extra-
cellular matrix remodeling. MMPs are present in and around
growing collateral arteries (Cai et al., 2003) and are essential for
collateral artery growth in a repetitive coronary occlusion model
(Dodd et al., 2011), and in a mesenteric arterial ligation model
(Haas et al., 2007). Monocytes and macrophages secrete MMPs in
large quantities; however, the relative contribution of MMP secre-
tion by macrophages to the increased MMP expression in and
around growing collateral arteries has not been defined.
Nitric oxide and redox state modulation
Monocytes/macrophages express inducible nitric oxide synthase
(iNOS). When induced, macrophages release abundant amounts
of nitric oxide in their antimicrobial defense against invading
pathogens, generating damaging concentrations of reactive oxy-
gen intermediates and peroxynitrite (ONOO–) that are normally
kept at low levels by superoxide dismutase, catalase, and peroxidase
at rest (Wong and Goeddel, 1988; Schmidt and Walter, 1994). This
may be relevant for arteriogenesis as well, since the importance of
the redox state on arteriogenesis has been reported (Rocic et al.,
2007).
The contribution of nitric oxide to arteriogenesis has previ-
ously been examined in experiments using NOS inhibitors (e.g.,
N -methyl-l-arginine-acetate or L-NNA), nitric oxide donors (e.g.,
S-nitroso-N -acetylpenicillamine or SNAP), eNOS–/– knockout
and eNOS transgenic mice, and an exercise training animal model
with acute arterial occlusion (Yang et al., 2002; Prior et al., 2003; Cai
et al., 2004; Mees et al., 2007). eNOS contributes to NO-mediated
vasodilation of peripheral collateral vessels, but its contribution to
arteriogenesis per se is still controversial (Yang et al., 2002; Prior
et al., 2003; Cai et al., 2004; Mees et al., 2007). Using iNOS–/–
knockout mice, a study suggested that iNOS may play a signif-
icant role in arteriogenesis, as abrogation of arteriogenesis in
eNOS–/– mice could only be achieved with addition of a rela-
tively selective iNOS inhibitor, l-N6-(1-iminoethyl)lysine (l-NIL;
Troidl et al., 2010). Moreover, the nitric oxide donor, diethylene-
triamine (DETA) NONOate strongly promoted collateral arterio-
genesis and activated perivascular monocytes that led the authors
to postulate that shear stress on monocytes may explain the effects
of iNOS in arteriogenesis (Troidl et al., 2010). Flow and shear stress
have been shown to induce iNOS in endothelial, vascular smooth
muscle cells, and mononuclear phagocytes/macrophages (Stuehr
et al., 1990; Beasley et al., 1991; Schmidt and Walter, 1994).
Cytokines
TNF-α is expressed by monocytes/macrophages around grow-
ing collateral arteries (Arras et al., 1998). Mononuclear phago-
cytes, especially the differentiating CD14+CD16+ macrophage-
like monocytes in transition from CD14+ inflammatory“classical”
monocytes, and differentiated macrophages are major sources of
TNF-α (Fingerle et al., 1993; Ziegler-Heitbrock et al., 1993; Belge
et al., 2002; Kawanaka et al., 2002). TNF-α is a proinflammatory
cytokine that has been reported to be important for arteriogene-
sis either related to its activation of TNF receptor 1 (Hoefer et al.,
2002) or, in a more severely ischemic hind limb model, TNF recep-
tor 2 (Luo et al., 2006). We found neither deficiency of TNF-α/β
nor that of TNF receptor 1 or 2 to affect perfusion recovery after
femoral artery ligation in mice (Helisch et al., 2003). Thus, the
exact role of TNF-α in arteriogenesis, remains unclear, also in light
of a recent study reporting M2-skewed macrophages as effectors
of arteriogenesis (Takeda et al., 2011). However, the release of
TNF-α is suppressed by IL-4 and IL-13, the Th2 cytokines that
promote M2-skewing of macrophages (Stein et al., 1992; Gordon
and Martinez, 2010).
PR39
A specific macrophage-derived antimicrobial peptide, PR39, deliv-
ered into the myocardium via adenoviral gene transfer was identi-
fied to improve collateral artery growth in a pig model of chronic
myocardial ischemia (Post et al., 2006), and in a murine hind
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limb ischemia model (Tirziu et al., 2005). In a mouse hind limb
ischemia study using the protein, we observed a strong tissue
protective effect of PR39 and related peptides, however, with-
out effect on blood flow recovery (Helisch et al., 2002), and
potentially explainable by anti-apoptotic effects (Wu et al., 2004).
The mechanism of PR39 is interesting, in that that it enhances
hypoxia-inducible factor-1α (HIF-1α)-dependent gene expression
by selectively inhibiting proteasome degradation of this transcrip-
tion factor (Li et al., 2000; Post et al., 2006). Adenoviral PR39
treatment resulted in increased local VEGF, VEGFR-1, VEGFR-2,
syndecan, and FGF receptors (FGFR)-1 levels. In addition, PR39
also stimulates expression of the FGFR-1 and syndecan-4, all of
which may contribute to arteriogenesis and tissue resistance to
ischemia (Post et al., 2006).
WHAT IS THE IMPORTANCE OF MONOCYTE/MACROPHAGE
POLARIZATION?
M2 macrophages have been ascribed pro-angiogenic properties
not observed in M1 cells in studies of tumor angiogenesis (Manto-
vani et al., 2009). A recent paper suggested that macrophage skew-
ing also plays a role in arteriogenesis (Takeda et al., 2011). Hap-
loinsufficiency of prolyl hydroxylase-2 (PHD2), an oxygen sensor
involved in the ubiquitin mediated proteasomal degradation of
hypoxia-inducible factor, resulted in an M2-like macrophage phe-
notype based on results from transcriptional profiling of Phd2+/−
murine peritoneal macrophages (Takeda et al., 2011). This study
was quite surprising in that the tissue protective effects of Phd2+/−
monocytes/macrophages seemed at least in part related to their
ability to increase the preexisting collateral vasculature before
arterial ligation! This effect on the preexisting collateral vas-
culature was associated with an increased accumulation of tis-
sue macrophages even at baseline. The skewing toward a pro-
arteriogenic phenotype reportedly relied on the activation of the
canonical NF-κB pathway and was associated with an increased
production of SDF-1 and PDGF-B (Takeda et al., 2011).
CONCLUSIONS
Collateral arteriogenesis is an important natural compensatory
mechanism in situations of tissue ischemia related to occlusive
arterial diseases. Understanding how collateral arteriogenesis can
be augmented may lead to development of therapeutic approaches
for patients with ischemic vascular diseases.
Recruitment of monocytes/macrophages to regions of collat-
eral artery growth has been observed in various animal models.
Initiation of the process requires mechanical forces related to the
increase of blood flow through innate collateral vessels occurring
after arterial occlusion. Although tissue ischemia may contribute
as a stimulus, collateral growth has been clearly demonstrated
to occur without local tissue ischemia. Published studies suggest
that monocytes/macrophages mediate arteriogenesis via paracrine
effects.
The extent of the effect of interventions designed to inhibit
or augment monocyte/macrophage recruitment in arteriogene-
sis or arteriolar remodeling in animal models has varied widely
from insignificant to large. The varying extent and severity of tis-
sue ischemia and necrosis in different models may explain some
of the outcome differences. In models with severe initial tissue
ischemia, final recovery may not primarily depend on vascular
growth processes, as these take time, however on the initial degree
of ischemia and tissue loss. Furthermore, we are not aware of an
animal model that provides a complete and selective elimination
of monocytes and macrophages. Thus, in our opinion, the degree
of monocyte/macrophage contribution to arteriogenesis remains
uncertain. The details of macrophage recruitment to preexisting
collateral vessels, and the potential importance of macrophage
subsets and skewing in arteriogenesis will remain to be
defined.
In humans, the role of monocytes/macrophages in collateral
development remains unclear. The impaired formation of collat-
erals in human diabetics may be due to impaired chemotaxis of
monocytes (e.g., toVEGF-A;Waltenberger et al., 2000; Tchaikovski
et al., 2009). In a study of 16 patients with coronary artery
disease, transcription profiling of monocytes showed differences
between patients with well-developed collateral vessels compared
to patients without angiographically visible collateral vessel.
The therapeutic efficacy of macrophage-related therapies
remains questionable. Data from clinical trials of GM-CSF and
G-CSF suggested an increase in collateral-dependent flow; how-
ever, the largest (n= 40 patient) study of patients with peripheral
artery disease did not show a difference between the intervention
and control groups. As discussed above, activating macrophages
(and angiogenesis) can worsen atherosclerosis, as shown in ani-
mal studies (e.g., MCP-1), and can trigger acute ischemic events
(as suggested in a clinical trial using GM-CSF).
A better understanding of myeloid cells and their subsets in col-
lateral arterial remodeling, and their involvement in atherogenesis,
atherosclerotic plaque stability, and tissue resistance to ischemia,
will be essential for the investigational field of “therapeutic
arteriogenesis.”
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